Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2023 Annual Meeting of Stockholders of Dynavax Technologies Corporation (the "Company") was held on May 26, 2023 in a virtual meeting format, pursuant to notice duly given (the "Annual Meeting"). Proxies for the Annual Meeting were solicited by the board of directors of the Company (the "Board") pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition to the Board's solicitations. As of April 3, 2023, the record date for the Annual Meeting, a total of 128,471,773 shares of Common Stock were outstanding and entitled to vote. There were 102,855,038 shares present in person or by proxy, constituting a quorum, at the Annual Meeting, at which the stockholders were asked to vote on four (4) proposals. Set forth below are the matters acted upon by the stockholders, and the final voting results of each such proposal. The proposals are described in detail in the Company's Proxy Statement.

Proposal 1. Election of Directors

The stockholders elected Daniel L. Kisner, M.D. and Ryan Spencer, as Class II directors of the Company to hold office until the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified. The voting for each director was as follows:




Nominee                 Votes Cast For      Votes Withheld    Broker Non-Votes
Daniel L. Kisner, M.D.       76,947,354           6,343,307          19,564,377
Ryan Spencer                 81,975,041           1,315,620          19,564,377

Proposal 2. Advisory Vote on Executive Compensation

The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. The votes were as follows:




   For       Against    Abstain   Broker Non-Votes
76,588,270   6,298,635  403,756      19,564,377


Proposal 3. Ratification of Selection of Independent Registered Public Accounting Firm

The stockholders ratified the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were as follows:




   For        Against    Abstain   Broker Non-Votes
91,793,935   10,915,466  145,637          N/A


Proposal 4. Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation

The stockholders approved, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers to occur once every one year as recommended by the Board of Directors. The votes were as follows:

Every One Year Every Two Years Every Three Years Abstain Broker Non-Votes


  80,678,723             128,201        2,219,297        264,440       19,564,377


Based on the Board's recommendation in the Proxy Statement, the voting results on this matter and the Board's consideration of the appropriate voting frequency for the Company at this time, the Board resolved that the Company will hold an advisory vote on the compensation of named executive officers every year.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses